Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.630

-5.8%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FiloF who wrote (2133)	3/24/2009 11:59:33 AM
From: richardred	Read Replies (3) of 7259

Drug stocks retreat while Allergan soars on speculation By Val Brickates Kennedy, MarketWatch Last update: 11:31 a.m. EDT March 24, 2009 BOSTON (MarketWatch) -- Drug stocks retreated a bit in early trading Tuesday, the day after the broader market staged an almost 500-point rally on hopes that a new government program will help rid the financial system of credit-crippling assets. AGN) Shares of the Botox-maker shot up over 10% to $47.70 in early trading amid rumors the company might soon be a takeover target for a major pharmaceutical company, possibly GlaxoSmithKline PLC, according to analysts. Glaxo shares were off almost 1% at $29.57. marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next